Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
NIRvana Sciences logo — Ultra-Narrow Emission Dyes and Probes

NIRvana Sciences

Ultra-Narrow Emission Dyes and Probes

Founded 2011 United States United States 8 employees Venture round Biotechnology, Life Sciences

General Information

Company Name NIRvana Sciences
Founded Year 2011
Location United States United States
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology, Life Sciences
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with NIRvana Sciences. To contact NIRvana Sciences, visit nirvanasciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NIRvana Sciences compare?

A PDF of NIRvana Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NIRvana Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NIRvana Sciences

NIRvana Sciences is a biotechnology and life sciences startup founded in 2011, specializing in the development of ultra-narrow emission dyes and probes. The company, spun out from the Department of Chemistry at North Carolina State University, is focused on commercializing novel fluorescent dyes with ultra-narrow emissions to enhance the performance of fluorescence-based medical diagnostic and imaging systems. The unique selling point of NIRvana Sciences lies in its ability to reduce detection complexities, thereby generating more accurate data for clinicians, and increasing multiplexing capabilities highly desired by researchers. These advancements in detection and sensitivity align with the industry trend of "Fewer Tests, More Answers," aimed at deriving more actionable data from each patient sample, ultimately improving the diagnosis and treatment regimens of patients affected by cancer or infectious disease. In May 2021, the company received a Venture - Series Unknown investment, signaling investor confidence in its innovative technology and commercial potential. NIRvana Sciences is currently focused on developing strategic partnerships with companies to integrate its dyes into a wide range of diagnostic and imaging platforms. With its location at the Alexandria Innovation Center in Research Triangle Park, North Carolina, the company is strategically positioned to collaborate with key industry players and leverage the region's robust biotechnology and life sciences ecosystem. For more information on NIRvana Sciences and its cutting-edge technology, visit their website.

Business keywords: Fluorescent dyes, Medical diagnostics, Imaging systems, Multiplexing capabilities, Cancer diagnosis, Infectious disease diagnostics, Technology development, Research partnerships, Diagnostic platforms, Fluorescence-based tests, Detection complexity reduction, Sensitivity improvement, Innovation commercialization, Partnership development

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Series Unknown Undisclosed -
27 May 2021
Grant Undisclosed -
25 Apr 2019
Venture Series Unknown Undisclosed -
19 Jul 2018
Series A Undisclosed -
30 Jun 2015
Seed Undisclosed -
15 Feb 2015
Grant Undisclosed -
01 Jan 2012

NIRvana Sciences Alternatives & Competitors

View All Alternatives
NIRvana Sciences vs
GRIP Molecular Technologies, Inc
GRIP Molecular Technologies, Inc United States

Transforming Medical Diagnostics

Non Equity Assistance
12 employees
Biotechnology, Health and Wellness
NIRvana Sciences vs
Milenia Biotec GmbH
Milenia Biotec GmbH Germany

Lateral Flow Rapid Tests and more

13 employees
Biotechnology, Health and Wellness
NIRvana Sciences vs
Aufbau Holdings
Aufbau Holdings

Aufbau Holdings develops treatments for vision-threatening eye diseases and systemic cancer through...

Venture round
Biotechnology, Health Care
View all alternatives

FAQ About NIRvana Sciences

Ultra-Narrow Emission Dyes and Probes
NIRvana Sciences was founded in 2011.
NIRvana Sciences is headquartered in United States.
NIRvana Sciences operates in Biotechnology and Life Sciences. Its work centres on Fluorescent dyes, Medical diagnostics, Imaging systems and Multiplexing capabilities.
NIRvana Sciences has approximately 8 employees.
NIRvana Sciences has completed 6 funding rounds. The latest funding stage is Venture round.
Top alternatives and competitors to NIRvana Sciences include GRIP Molecular Technologies, Inc, Milenia Biotec GmbH, Aufbau Holdings, Biotronics3D Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NIRvana Sciences and GRIP Molecular Technologies, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NIRvana Sciences, https://bouncewatch.com/company/nirvana-sciences, updated 15 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes